Today: 7 February 2026
Subscribe
Browse Category

NYSE:CI News 9 January 2026 - 6 February 2026

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health (OSCR) stock slips again in premarket as insurer cost fears spread ahead of earnings

Oscar Health shares fell 2.3% to $12.22 in premarket trading Friday after a 5.4% drop Thursday, as investors reacted to Molina Healthcare’s profit warning and exit from Medicare Part D. Molina’s stock plunged nearly 35% after hours, dragging other managed-care stocks lower. Oscar reports earnings Feb. 10, with investors watching for updates on 2026 enrollment and claims.
6 February 2026
·······
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna shares rose 3.2% to $280.46 after posting Q4 adjusted earnings of $8.08 per share, above forecasts, though its 2026 outlook missed estimates. Express Scripts agreed to a 10-year FTC settlement on insulin pricing, expected to cut patient costs by up to $7 billion. Evernorth pharmacy revenue jumped 20% to $36.3 billion. Cigna’s board raised its quarterly dividend to $1.56 per share.
5 February 2026
·····
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·······
UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth stock price slides 3% as Optum pricing study and FTC pressure keep UNH in focus

UnitedHealth shares fell about 3% Wednesday, closing at $275.58, after a Cornell study linked Optum’s surgery-center acquisitions to an 11% price hike in commercial claims. Investors are watching for Medicare Advantage rate decisions in April amid ongoing regulatory scrutiny of UnitedHealth’s Optum and other managed-care firms.
4 February 2026
······
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
··········
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·······
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

New York, Jan 24, 2026, 13:07 EST — Market closed. The Health Care Select Sector SPDR Fund (XLV) dropped 0.51% to close at $157.48 on Friday. The S&P 500 Health Care index also slipped, down 0.56% by the closing bell. (Investing.com) This week matters because politics, payment rules, and earnings collide. The biggest players might act like defensives—until a reimbursement change or a Washington headline shifts the calculus. Investors seem to be demanding proof over promises following a jittery January. While health care sectors have shown some resilience, they haven’t provided a clear safe haven. The Dow dropped 0.58% on
24 January 2026
········
UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

UnitedHealth stock rises as CEO heads to Congress with Obamacare rebate pledge

New York, Jan 22, 2026, 11:27 (ET) — Regular session Shares of UnitedHealth Group Incorporated climbed 1.8%, closing at $353.85 on Thursday, up $6.10. The move came as investors digested the insurer’s pledge to rebate profits from its Obamacare segment amid renewed scrutiny from lawmakers. The company announced it will offer rebates to customers on its Affordable Care Act (ACA) marketplace plans in 2026, following the expiration of enhanced federal tax credits that had previously lowered premiums. Premiums are set to jump to an average of $1,904 in 2026, up from $888 in 2025, according to KFF, a health policy
22 January 2026
······
UnitedHealth stock drops today — what traders are watching before UNH earnings

UnitedHealth stock drops today — what traders are watching before UNH earnings

New York, Jan 16, 2026, 11:53 EST — Regular session UnitedHealth Group Incorporated (UNH) shares dipped roughly 1.3% on Friday, closing at $334.40. As the Dow pulled back, the largest health insurer by market cap turned into one of its biggest drags. (MarketWatch) The pullback follows President Donald Trump’s healthcare proposal, unveiled just a day earlier, which would swap government insurance subsidies for direct payments to consumers—a move that could upend the way coverage is bought and priced. Insurer stocks jumped on Thursday after the announcement, though the plan lacks specifics and faces a split Congress. (Reuters) Investors are watching
16 January 2026
·········
UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope

UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope

New York, Jan 13, 2026, 19:13 EST — After-hours Shares of UnitedHealth Group Incorporated dropped nearly 2% Tuesday, deepening a retreat sparked by a U.S. Senate report scrutinizing how the insurer logs diagnoses in Medicare Advantage. Humana, Elevance Health, and Cigna also saw declines. The report comes at a tricky point for the sector. Insurers are pushing to reassure investors they can steady margins following a tough run under government plans, even as lawmakers and regulators ramp up scrutiny on billing and audits. Medicare Advantage is managed by private insurers but funded by the federal government. These plans get a
14 January 2026
······
UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

UnitedHealth (UNH) stock slips as Congress summons CEO; investors eye earnings date

New York, Jan 9, 2026, 19:28 EST — After-hours UnitedHealth Group shares fell roughly 0.8% on Friday, lingering around $344 in after-hours trading as U.S. lawmakers intensified scrutiny of major insurers ahead of hearings scheduled for later this month. (stockanalysis.com) The hearings are significant as policy uncertainty is creeping back into managed care valuations. Investors have promptly pushed down the group whenever Washington discusses premiums, subsidies, or regulation. UnitedHealth faces tricky timing. It’s gearing up to update guidance for 2026 just as lawmakers prepare to press the company on costs and coverage issues. Leaders of the House Energy and Commerce
10 January 2026
·······
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

New York, Jan 8, 2026, 20:57 (ET) — Market closed U.S. House lawmakers have called on UnitedHealth Group Incorporated (UNH.N) and four other major insurers to testify on coverage affordability later this month, signaling growing Washington scrutiny. UnitedHealth shares rose 1.5% to close at $346.85 on Thursday. The House Energy and Commerce Committee and the Ways and Means Committee extended invitations to UnitedHealth, CVS Health, Cigna, Elevance and Ascendia for testimony on Jan. 22. Reuters The timing is sensitive. Congress is once again locked in a dispute over subsidies under the Affordable Care Act, known as Obamacare, a debate that
9 January 2026
·······
1 2

Stock Market Today

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop